1. Cell Cycle/DNA Damage Epigenetics Metabolic Enzyme/Protease Immunology/Inflammation NF-κB Apoptosis
  2. PARP DNA/RNA Synthesis Reactive Oxygen Species (ROS) Apoptosis
  3. PARP1-IN-49

PARP1-IN-49 is a selective PARP1 inhibitor with an IC50 of 23.56 nM and a Kd of 17.78 nM. PARP1-IN-49 shows a selectivity for PARP1 over PARP2. PARP1-IN-49 leads to the induction of DNA damage, cell cycle arrest, and apoptosis. PARP1-IN-49 also increases intracellular ROS levels and inhibits cell migration. PARP1-IN-49 can be used for the research of breast cancer and ovarian cancer.

For research use only. We do not sell to patients.

PARP1-IN-49

PARP1-IN-49 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

PARP1-IN-49 is a selective PARP1 inhibitor with an IC50 of 23.56 nM and a Kd of 17.78 nM. PARP1-IN-49 shows a selectivity for PARP1 over PARP2. PARP1-IN-49 leads to the induction of DNA damage, cell cycle arrest, and apoptosis. PARP1-IN-49 also increases intracellular ROS levels and inhibits cell migration. PARP1-IN-49 can be used for the research of breast cancer and ovarian cancer[1].

IC50 & Target[1]

PARP1

23.56 nM (IC50)

PARP1

17.78 nM (Kd)

PARP2

285.39 nM (IC50)

In Vitro

PARP1-IN-49 (compound 9a) (0.5-2 μM; 48 h) inhibits MDA-MB-231 cell proliferation and migration[1].
PARP1-IN-49 (0.5-2 μM; 48 h) increases apoptosis-related protein expression and decreases Bcl-2 levels in MDA-MB-231 cells[1].
PARP1-IN-49 (0.5-2 μM; 48 h) induces DNA damage and double-strand breaks MDA-MB-231 cells[1].
PARP1-IN-49 (0.5-2 μM; 48 h) increases apoptosis and causes S phase cell cycle arrest MDA-MB-231 cells[1].
PARP1-IN-49 (0.5-4 μM; 48 h) induces apoptosis via ROS generation and altered mitochondrial membrane potential MDA-MB-231 cells[1].
PARP1-IN-49 (2 μM; 48 h) enhances PARP1 thermal stability, indicating direct interaction[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Cell Proliferation Assay[1]

Cell Line: MDA-MB-231 cells
Concentration: 0.5 μM, 1 μM, 2 μM
Incubation Time: 48 h
Result: Inhibited cell proliferation and migration in a dose-dependent manner.

Western Blot Analysis[1]

Cell Line: MDA-MB-231 cells
Concentration: 0.5 μM, 1 μM, 2 μM
Incubation Time: 48 h
Result: Induced apoptosis in a dose-dependent manner, increasing the expression of apoptosis-related proteins, such as Cleaved PARP, Cleaved caspase3 and Bax, and decreasing Bcl-2 protein levels.

Immunofluorescence[1]

Cell Line: MDA-MB-231 cells
Concentration: 0.5 μM, 1 μM, 2 μM
Incubation Time: 48 h
Result: Induced DNA damage and the accumulation of double-strand breaks, as indicated by increased γH2AX and comet tail length.

Cell Cycle Analysis[1]

Cell Line: MDA-MB-231 cells
Concentration: 0.5 μM, 1 μM, 2 μM
Incubation Time: 48 h
Result: The proportion of cells in the S phase increased from 20.09% to 47.56%, while the proportion of cells in the G2/M phase decreased from 19.11% to 6.58%.

Apoptosis Analysis[1]

Cell Line: MDA-MB-231 cells
Concentration: 0.5 μM, 1 μM, 2 μM
Incubation Time: 48 h
Result: The proportion of cells undergoing early and late apoptosis increased from 0.49% to 53.8%. 
Parmacokinetics
Species Dose Route Note Tmax Cmax AUC0-t T1/2 MRT
Rat[1] 5 mg/kg i.p. 文献审核 0.39 h 6993.33 ng/mL 11115.57 ng·h/mL 1.5 h 1.13 h
In Vivo

PARP1-IN-49 (compound 9a) (20, 40 mg/kg; Intraperitoneal; 22 days) significantly inhibits tumor growth in MDA-MB-231 cells subcutaneously inoculated into BALB/c mice[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: MDA-MB-231 cells (1 × 107 cells) were subcutaneously inoculated into the right flank of BALB/c nude mice (4-week-old)[1]
Dosage: 20 mg/kg, 40 mg/kg
Administration: Intraperitoneal; 22 days
Result: Tumor growth was significantly inhibited.
Molecular Weight

286.26

Formula

C15H11FN2O3

SMILES

O=C(NC)C1=CC(C2=CC=C(OC(N3)=O)C3=C2)=CC(F)=C1

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
PARP1-IN-49
Cat. No.:
HY-179406
Quantity:
MCE Japan Authorized Agent: